Oppenheimer Reiterates a Hold Rating on Seattle Genetics

Marco Green
August 30, 2017

The firm earned "Hold" rating on Monday, June 26 by Cantor Fitzgerald. The stock of Western Refining Logistics LP (NYSE:WNRL) has "Overweight" rating given on Wednesday, August 5 by Barclays Capital. Seattle Genetics, Inc. (NASDAQ:SGEN) for the trailing twelve months paying dividend with the payout ratio of 0.00% to its shareholders. Therefore 6% are positive.

Turning to Seattle Genetics, Inc. The stock was sold at an average price of $47.54, for a total transaction of $475,400.00. Zacks Investment Research upgraded Seattle Genetics from a "sell" rating to a "hold" rating in a research report on Tuesday, May 2nd. On Thursday, June 15 the stock rating was maintained by Oppenheimer with "Hold". Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. (NASDAQ:SGEN) rating on Tuesday, June 6. RBC Capital Markets has "Outperform" rating and $54 target. The firm has "Outperform" rating given on Friday, August 14 by Leerink Swann. The legal version of this report can be read at https://www.truebluetribune.com/2017/08/29/seattle-genetics-inc-sgen-receives-hold-rating-from-cantor-fitzgerald.html. Seattle Genetics Inc (SGEN) has a current ROIC of -21.23. The rating was maintained by Oppenheimer with "Hold" on Thursday, June 15. Baker Bros Advisors Lp who had been investing in Seattle Genetics Inc. for a number of months, seems to be bullish on the $6.97 billion market cap company. The Company is involved in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. The stock spiked 1.04% last month and is up 51.61 this year. The Company's marketed product ADCETRIS, or brentuximab vedotin, is an antibody-drug conjugate (ADC).

Since March 6, 2017, it had 0 buys, and 6 selling transactions for $4.72 million activity. Seattle Genetics Inc now has $7.04B valuation. Shares for $984,259 were sold by SIEGALL CLAY B on Monday, March 6. HIMES VAUGHN B sold $625,922 worth of stock. The NASDAQ listed company saw a recent bid of 47.99 and 139251 shares have traded hands in the session.

Seattle Genetics (NASDAQ:SGEN) last issued its quarterly earnings results on Thursday, July 27th. It has outperformed by 58.98% the S&P500.

Investors sentiment decreased to 1.3 in Q4 2016. Next quarter's EPS is forecasted at $-0.45 with next year's EPS projected to be $-1.16. The ratio increased, as 124 hedge funds started new and increased equity positions, while 103 sold and decreased holdings in Seattle Genetics Inc. Sold All: 30 Reduced: 73 Increased: 64 New Position: 60. 135.77 million shares or 1.02% less from 137.16 million shares in 2016Q3 were reported. The New York-based Barrett Asset Management Ltd Liability Corporation has invested 0.04% in General Mills, Inc. Macquarie Group stated it has 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN). Amalgamated Commercial Bank holds 17,143 shares.

Blackrock Inc increased Stryker Corp (SYK) stake by 4.15% reported in 2016Q4 SEC filing. (NASDAQ:SGEN). Commercial Bank Of America De owns 452,927 shares or 0.01% of their U.S. portfolio. Us Savings Bank De holds 6,037 shares. (NASDAQ:SGEN). Quantitative Inv Mngmt Limited Co reported 88,500 shares. Days to cover decreased -2.3 to 12.0 and the percentage of shorted shares was 0.08% on August 15. National Bank & Trust Of Ny Mellon Corp holds 0.01% of its portfolio in Seattle Genetics, Inc. Pinnacle Associates Ltd holds 1.18% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN) or 93,878 shares. Grandfield And Dodd Ltd Liability Corporation has 0.06% invested in Seattle Genetics, Inc. Wasatch Advisors Inc, Utah-based fund reported 2.73 million shares. Emory University has 1.54% invested in Seattle Genetics, Inc. Moreover, Channing Capital Management Llc has 2.16% invested in the company for 1.56 million shares. XRF Scientific Limited (ASX:XRF) has 0.00% since August 28, 2016 and is. It has underperformed by 16.70% the S&P500.The move comes after 5 months negative chart setup for the $22.75M company.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER